Global Non-interventional Heart Failure Disease Registry

Exclusion Criteria

• •1-Concomitant participation in any/a clinical trial with any investigational treatment (for any sponsor).
• •2\. Use of investigational drugs within 5 half-lives of enrollment, or until the expected pharmacodynamic effect has returned to baseline, whichever is longer.